Arvinas, Inc. Common Stock ARVN
i
Market dataready · fetched 2026-11-04T03:52:23.050Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-03T21:00:02.935455127Z
FundamentalsSEC EDGAR · ready · as of 2026-09-30 · fetched 2026-11-04T03:52:22.613777+00:00
Arvinas, Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 5.31 | 243.5% | 33.6% | |||
| 25Δ | 7.93 | 66.5% | 13.9% | 5.74 | 272.7% | 31.9% |
| 30Δ | 7.79 | 65.7% | 12.5% | |||
| 35Δ | 7.64 | 64.9% | 11.0% | |||
| 40Δ | 7.49 | 64.1% | 9.6% | |||
| 45Δ | 7.35 | 63.3% | 8.2% | 7.19 | 82.0% | 7.0% |
| 50Δ | 7.20 | 62.5% | 6.7% | 7.73 | 92.1% | 6.4% |
| 55Δ | 7.06 | 61.7% | 5.3% | 8.28 | 102.1% | 5.7% |
| 60Δ | 8.82 | 112.2% | 5.1% | |||
| 65Δ | 9.36 | 122.3% | 4.4% | |||
| 70Δ | 9.90 | 132.4% | 3.8% | |||
| 75Δ | 10.44 | 142.4% | 3.1% | |||
| 80Δ | 5.43 | 176.4% | 4.9% | 10.99 | 152.5% | 2.5% |
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 5.31
- IV
- 243.5%
- B/E move
- 33.6%
25Δ
- Pseudo strike
- 7.93
- IV
- 66.5%
- B/E move
- 13.9%
- Pseudo strike
- 5.74
- IV
- 272.7%
- B/E move
- 31.9%
30Δ
- Pseudo strike
- 7.79
- IV
- 65.7%
- B/E move
- 12.5%
- Pseudo strike
- IV
- B/E move
35Δ
- Pseudo strike
- 7.64
- IV
- 64.9%
- B/E move
- 11.0%
- Pseudo strike
- IV
- B/E move
40Δ
- Pseudo strike
- 7.49
- IV
- 64.1%
- B/E move
- 9.6%
- Pseudo strike
- IV
- B/E move
45Δ
- Pseudo strike
- 7.35
- IV
- 63.3%
- B/E move
- 8.2%
- Pseudo strike
- 7.19
- IV
- 82.0%
- B/E move
- 7.0%
50Δ
- Pseudo strike
- 7.20
- IV
- 62.5%
- B/E move
- 6.7%
- Pseudo strike
- 7.73
- IV
- 92.1%
- B/E move
- 6.4%
55Δ
- Pseudo strike
- 7.06
- IV
- 61.7%
- B/E move
- 5.3%
- Pseudo strike
- 8.28
- IV
- 102.1%
- B/E move
- 5.7%
60Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 8.82
- IV
- 112.2%
- B/E move
- 5.1%
65Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 9.36
- IV
- 122.3%
- B/E move
- 4.4%
70Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 9.90
- IV
- 132.4%
- B/E move
- 3.8%
75Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 10.44
- IV
- 142.4%
- B/E move
- 3.1%
80Δ
- Pseudo strike
- 5.43
- IV
- 176.4%
- B/E move
- 4.9%
- Pseudo strike
- 10.99
- IV
- 152.5%
- B/E move
- 2.5%
Options history
Table
| Date | IV (%) |
|---|---|
| 88.98% | |
| 70.69% | |
| 76.59% | |
| 101.31% | |
| 106.76% | |
| 108.44% | |
| 96.78% | |
| 101.08% | |
| 93.14% | |
| 99.81% |
Biotechnology
ARWR
Arrowhead Pharmaceuticals, Inc. develops drugs for the treatment of intractable diseases in the United States. The company is headquartered in Pasadena, California.
More →ASMB
Assembly Biosciences, Inc. is a clinical-stage biotechnology company in the United States. The company is headquartered in South San Francisco, California.
More →ASND
Ascendis Pharma A / S, a biopharmaceutical company, develops therapies for unmet medical needs. The company is headquartered in Hellerup, Denmark.
More →ATNM
Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplantation (BMT) or a type of…
More →ATOS
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops drugs in the areas of oncology and infectious diseases. The company is headquartered…
More →AUPH
Description unavailable
More →